LPCN · Lipocine Inc.
AI read · Good for LPCN
The AI's read
The approval gives TLANDO a path into a country where doctors already write many testosterone-replacement prescriptions. Verity holds the sales rights and is still planning the launch for the end of 2026, so Canadian sales are not immediate. The approval is a step forward for Lipocine, despite the wait.